Assessment of patients’ characteristics associated with the efficacy and safety of oral valganciclovir treatment for infants with symptomatic congenital cytomegalovirus disease
Authors:
- Yasumasa KakeiYKYasumasa Kakei
- Ichiro MoriokaIMIchiro Morioka
- Takumi ImaiTITakumi Imai
- Kotaro ItoharaKIKotaro Itohara
- Ikuko YanoIYIkuko Yano
- Naoto TakahashiNTNaoto Takahashi
- Tetsushi YoshikawaTYTetsushi Yoshikawa
- Hiroyuki MoriuchiHMHiroyuki Moriuchi
- Yoshinori ItoYIYoshinori Ito
- Kazumichi FujiokaKazumichi Fujioka
- Akira OkaAOAkira Oka
- Aya OkahashiAOAya Okahashi
- 13 March 2024
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 30 (10) , 971-977
Abstract
No abstract availableKeywords
Funding Information
- AMED
This publication has 16 references indexed in Scilit:
- Clinical outcome and the role of antivirals in congenital cytomegalovirus infectionAntiviral Research, 2021
- Efficacy, safety, and pharmacokinetics of oral valganciclovir in patients with congenital cytomegalovirus infectionJournal of Infection and Chemotherapy, 2021
- Efficacy and safety of valganciclovir in patients with symptomatic congenital cytomegalovirus diseaseMedicine, 2020
- Pediatric Dosing of Ganciclovir and Valganciclovir: How Model‐Based Simulations Can Prevent Underexposure and Potential Treatment FailureCPT: Pharmacometrics & Systems Pharmacology, 2018
- Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapyThe Lancet Infectious Diseases, 2017
- Bottom‐up Meets Top‐down: Complementary Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling for Regulatory Approval of a Dosing Algorithm of Valganciclovir in Very Young ChildrenClinical Pharmacology & Therapeutics, 2016
- Neurological outcomes in symptomatic congenital cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatmentBrain and Development, 2016
- Valganciclovir for Symptomatic Congenital Cytomegalovirus DiseaseNew England Journal of Medicine, 2015
- Population pharmacokinetics of valganciclovir prophylaxis in paediatric and adult solid organ transplant recipientsBritish Journal of Clinical Pharmacology, 2014
- Ganciclovir Population Pharmacokinetics in Neonates Following Intravenous Administration of Ganciclovir and Oral Administration of a Liquid Valganciclovir FormulationClinical Pharmacology & Therapeutics, 2007